Search TECH
BIO-TECHNE Corp
Nasdaq · CIK 842023
Last close72.4
Daily change+0.00 (0.00%)
10 Years gain+175.76%
Dividends TTM0.32 (+0.00%)
Dividend yield0.44%
Fundamental Analysis
TECH · STANDARD
SIC 2836 · Biological Products, (No Diagnostic Substances) · Fiscal year end 0630
Fundamental
47.2Momentum
36.9Acceleration
35.1Confidence
100.0Annual Revenue18
Quarterly Revenue61
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth2.9 / 25
Quality14.1 / 25
Capital Efficiency3.5 / 20
Balance Sheet14.3 / 15
Shareholder Economics7.3 / 10
Forward Indicators5.0 / 5
Signals
Gross margin expansionGross margin improved by 0.0191 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 2.0065%.
Warnings
FCF deterioration · MEDIUMFree cash flow declined 23.1291%.
Operating margin compression · MEDIUMOperating margin compressed by 2.6211 percentage points.
ROIC declining · MEDIUMROIC declined by 3.52 percentage points.
Key Metrics
Revenue Growth TTM5.56%OK
Revenue CAGR 3Y2.25%OK
Gross Margin66.3%OK
Operating Margin17.88%OK
FCF Margin17.13%OK
FCF Growth-23.13%OK
ROIC8.24%OK
Incremental Operating Margin 3Y-83.65%OK
Net Debt / CFO-0.88xOK
Diluted Share Growth 1Y-2.01%OK
SBC / Revenue3.93%OK
SBC / FCF22.93%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jun 30, 2026 | $1.22B | $799.07M | $251.89M | $292.07M | $263.22M | 65.77% | 20.73% | 21.66% | 10.57% | 157.01M |
| 2026 FY Jun 30, 2025 | $1.22B | $790.27M | $102.26M | $287.56M | $256.55M | 64.8% | 8.38% | 21.04% | 4.15% | 159.72M |
| 2026 FY Jun 30, 2024 | $1.16B | $769.73M | $206.69M | $298.98M | $236.10M | 66.41% | 17.83% | 20.37% | 10.17% | 160.77M |
| 2025 FY Jun 30, 2023 | $1.14B | $769.82M | $298.94M | $254.39M | $216.15M | 67.72% | 26.3% | 19.02% | 15.6% | 161.86M |
| 2024 FY Jun 30, 2022 | $1.11B | $756.50M | $296.59M | $325.27M | $280.36M | 68.42% | 26.83% | 25.36% | 18.42% | 164.11M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.21B | sum latest 4 fiscal quarters Revenue | OK | 0001104659-26-056302, 0001104659-25-107053 |
| Revenue Growth TTM | 5.56% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104659-26-056302, 0001104659-25-107053 |
| Revenue CAGR 3Y | 2.25% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-100322 |
| Revenue CAGR 5Y | 5.47% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001104659-26-100322 |
| Gross Profit CAGR 3Y | 1.25% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-100322 |
| Operating Income Growth | -7.94% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001104659-26-056302, 0001104659-25-107053 |
| FCF Growth | -23.13% | FCF_current / FCF_prior_year - 1 | OK | 0001104659-26-056302, 0001104659-26-010335 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 66.3% | Gross Profit / Revenue | OK | 0001104659-26-056302, 0001104659-25-107053 |
| Operating Margin | 17.88% | Operating Income / Revenue | OK | 0001104659-26-056302, 0001104659-25-107053 |
| FCF Margin | 17.13% | (CFO - CapEx) / Revenue | OK | 0001104659-26-056302, 0001104659-26-010335 |
| CFO / Net Income | 1.59x | CFO / Net Income | OK | 0001104659-26-056302, 0001104659-26-010335 |
| FCF / Net Income | 1.38x | FCF / Net Income | OK | 0001104659-26-056302, 0001104659-26-010335 |
| ROIC | 8.24% | NOPAT / Average Invested Capital | OK | 0001104659-26-056302, 0001104659-25-107053 |
| Net Debt / CFO | -0.88x | Net Debt / CFO | OK | 0001104659-26-056302, 0001104659-26-010335 |